Also trades as: PAVMW (NASDAQ) · $vol 0M
PAVM NASDAQ
PAVmed Inc.
1W: -25.4%
1M: -46.4%
3M: -46.0%
YTD: -60.9%
1Y: +552.3%
3Y: -39.2%
5Y: -97.9%
$2.87
+0.17 (+6.30%)
Weekly Expected Move ±16.4%
$2
$2
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
13 relationships13
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-10-18
Earliest Filing
2025-04-17
Latest Filing
partner: 12
target: 1
Counterparties (Filed by PAVM)
13 relationshipsCompanies named in PAVM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Maxim Group LLC | MMS | partner | Sales agent for the issuance and sale of Placement Shares | 2025-04-17 | View |
| Lucid Diagnostics Inc. | LUCD | partner | Company holds shares of Lucid Diagnostics Inc. and notes are exchangeable for its common stock. | 2024-11-21 | View |
| Lucid Diagnostics | LUCD | partner | Subsidiary being deconsolidated from PAVmed's financial statements | 2024-09-16 | View |
| Veris Health Inc. | — | partner | Digital health subsidiary of PAVmed | 2024-09-16 | View |
| Lucid Diagnostics Inc. | LUCD | partner | Majority owned subsidiary whose common stock was distributed to PAVmed Inc. stockholders via a special pro rata dividend | 2024-02-16 | View |
| Lucid Diagnostics Inc. | LUCD | partner | Majority-owned subsidiary of PAVmed Inc. that entered into a Common Stock Purchase Agreement with Cantor Fitzgerald. | 2022-04-01 | View |
| Cantor Fitzgerald | — | partner | Parent affiliate of CF Principal Investments LLC involved in the equity facility agreement. | 2022-04-01 | View |
| ResearchDx, Inc. | — | partner | Counterparty to a Management Services Agreement with LucidDx Labs Inc. | 2022-04-01 | View |
| Lucid Diagnostics Inc. | LUCD | partner | Majority owned subsidiary of PAVmed Inc. that entered into an asset purchase agreement and management services agreement | 2022-03-03 | View |
| LucidDx Labs Inc. | LCID | partner | Wholly owned subsidiary of Lucid Diagnostics Inc. that acquired assets and entered into a management services agreement. | 2022-03-03 | View |
| ResearchDx, Inc. | — | partner | Company that sold assets and provided management services to LucidDx Labs. | 2022-03-03 | View |
| Endeavour Investments, LLC | — | partner | Affiliate of ResearchDx, Inc. that leased laboratory space to LucidDx Labs. | 2022-03-03 | View |
| Lucid Diagnostics Inc. | LUCD | target | PAVmed Inc. purchased majority ownership in Lucid Diagnostics Inc. following its initial public offering. | 2021-10-18 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-10 | Material Agreement; Exhibits | Agreement | View |
| 2026-08-14 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-06-24 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-15 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-03-27 | Officer/Director Change; Bylaws Amendment; Shareholder Vote; Exhibits | View | |
| 2026-02-04 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Creation of | Agreement | View |
| 2026-01-23 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-30 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-12-05 | Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits | View | |
| 2025-11-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-09-11 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-14 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-30 | Other Events; Financial Statements and Exhibits | View | |
| 2025-06-24 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-06-18 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-15 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-04-25 | Changes in Registrant's Certifying Accountant; Financial Statements and Exhibits | View | |
| 2025-04-17 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-04-11 | Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR